Drug
Soybean oil, phospholipid emulsion clinical trials
- studies test it
- 46
- open now
- 3
- in phase 3
- 8
- first study started
- 2004
Keep track of what changes. Save the soybean oil, phospholipid emulsion studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
46 studies that test it; most in 2012 (5)
| Year | Studies |
|---|---|
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 5 |
| 2013 | 3 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 5 |
| 2022 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 3
- Phase 1
- 5
- Phase 2
- 9
- Phase 3
- 8
- Phase 4
- 12
- No phase
- 16
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 45
Mayo Clinic (3) · Emory University (3) · Ain Shams University (2) · Woman's Health University Hospital, Egypt (2) · Cairo University (2) · Hospital for Special Surgery, New York (1) · University of Pennsylvania (1) · Indiana University (1)
Often tested with
Tested in the same studies.
SMOFlipid (4) · Heparin (4) · ClinOleic (3) · Saline Solution (2) · Glucose (2) · Fish oil triglycerides (2) · Mitoquinone (1) · Galantamine (1)
Studies
Open first, then newest update. How each study uses soybean oil, phospholipid emulsion is read from its arms, and is right about nine times in ten.
Testing it · 46
- Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of LipidsRecruitingNot applicableMayo ClinicNCT03818178Written as Intralipid
- Reversing Glucose and Lipid-mediated Vascular DysfunctionRecruitingEarly Phase 1University of Kansas Medical CenterNCT04832009Written as Intralipid
- Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and MetabolismRecruitingPhase 1/2University of North Carolina, Chapel HillNCT04328337Written as Intralipid, 20% Intravenous Emulsion
- Low Dose Fat-Induced Insulin ResistanceCompletedEarly Phase 1University of PennsylvaniaNCT03479671Written as Intralipid, 20% Intravenous Emulsion
- Intralipid® 20% for Reversal of Local AnestheticsActive, not recruitingPhase 4Hospital for Special Surgery, New YorkNCT03968822Written as Intralipid, 20% Intravenous
- Role of Intralipid in Management of Organophosphorus PoisoningWithdrawnPhase 2/3Amani Hassan Abdel-WahabNCT04393103Written as Intralipid, 20% Intravenous Emulsion
- Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical NeonatesCompletedPhase 3Indiana UniversityNCT03387579Written as Intralipid, 20% Intravenous Emulsion
- Intralipid Versus SMOFlipid in HPN PatientsCompletedNot applicableMayo ClinicNCT03773237Written as Intralipid
- The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature NewbornsCompletedPhase 4The University of Texas Health Science Center, HoustonNCT03857646Written as Intralipid, 20% Intravenous Emulsion
- Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or OxaliplatinCompletedNot applicableMayo ClinicNCT03122886Written as Fat Emulsion
- Fatty Acid Oxidation Defects and Insulin SensitivityCompletedNot applicableOregon Health and Science UniversityNCT02517307Written as Intralipid/Heparin
- Neuroimmune Mechanisms in ObesityWithdrawnPhase 1Yale UniversityNCT05553405Written as Intralipid Infusion
- Mitochondrial Dysfunction and Insulin Resistance in Skeletal MuscleCompletedNot applicableUniversity of CopenhagenNCT04558190Written as Intralipid, 20% Intravenous Emulsion
- Dynamics of Muscle Mitochondria in Type 2 Diabetes (DYNAMMO T2D)CompletedEarly Phase 1Pennington Biomedical Research CenterNCT02697201Written as Intralipid
- Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?WithdrawnPhase 4Tanta UniversityNCT04274803Written as Intralipid, 20% Intravenous Emulsion
- The Cardioprotective Effect of Intralipid in Decreasing the Ischemic Insults During Off-pump Coronary Artery RevascularizationCompletedPhase 4Ain Shams UniversityNCT04806425Written as Intralipid
- Intralipid Therapy for Recurrent Implantation Failure and Recurrent Miscarriages: Is it a Hope or Myth?A Randomized Clinical TrialWithdrawnPhase 4Woman's Health University Hospital, EgyptNCT01679561Written as intralipid
- Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALDCompletedPhase 3University of MichiganNCT02357576Written as Intralipid 20% I.V. Fat Emulsion
- Intralipid Therapy for Women 35-40 Years With Positive Natural Killer Cells Undergoing Intracytoplasmic Sperm Injection (ICSI)TerminatedPhase 3Cairo UniversityNCT01916798Written as Intralipid infusion
- Lipid Infusion Following Major SurgeryWithdrawnNot applicableUniversity of AlbertaNCT02463812Written as Intralipid
See all 46 studies that test soybean oil, phospholipid emulsion →
Given in every arm · 4 — soybean oil, phospholipid emulsion is usual care beside what is tested
- Safety and Feasibility Study of Methylene Blue Photodynamic Therapy to Sterilize Deep Tissue Abscess CavitiesCompletedPhase 1University of RochesterNCT02240498Written as 20% I.V. Fat Emulsion
- Free Fatty Acids-Induced Hypertension in Obese Subjects (Aim #2)CompletedNot applicableEmory UniversityNCT02406586Written as Intralipid 20%
- Immune Modulation by Parenteral Fish Oil in Patients With Crohn's DiseaseCompletedPhase 4Radboud University Medical CenterNCT02349594Written as Intralipid 20%
- Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 DiabetesCompletedPhase 4Emory UniversityNCT00738023Written as Intralipid 20%
As the comparator · 18 — what is tested is compared with soybean oil, phospholipid emulsion
- Comparison of Intralipid With SMOF Lipid Following HSCTRecruitingNot applicableShahid Beheshti UniversityNCT06625372Written as INTRALIPIDS
- Reprometabolic Syndrome Mediates Subfertility in ObesityActive, not recruitingNot applicableUniversity of Colorado, DenverNCT02653092Written as Intralipid
- Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell TransplantationCompletedPhase 1Alexandra N. CareyNCT02512718Written as Soybean oil lipid emulsion
- Intravenous Nutrition in Hospitalized Patients: Comparison of Two OilsCompletedPhase 4Johane AllardNCT01943409Written as Intralipid
- Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)CompletedPhase 4Baxter Healthcare CorporationNCT04555044Written as Intralipid
- Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of PrematurityCompletedPhase 2University of California, San DiegoNCT02486042Written as Standard lipids (primarily omega-6 fatty acids)
- Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of AgeTerminatedPhase 4Fresenius KabiNCT03563222Written as Intralipid, 20%
- Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and InfantsTerminatedPhase 3Fresenius KabiNCT02579265Written as Intralipid® 20%
- Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid EmulsionTerminatedPhase 4Baxter Healthcare CorporationNCT02476994Written as Intralipid
- Cholestasis Prevention: Efficacy of IV Fish OilCompletedPhase 1Boston Children's HospitalNCT00512629Written as Intralipid
- Omega 3 Fatty Acid Treatment for Pediatric Musculoskeletal HealthWithdrawnPhase 2Boston Children's HospitalNCT03127345Written as Intralipid
- Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPNCompletedPhase 2/3Emory UniversityNCT00672854Written as Intralipid, 20% Intravenous Emulsion
- Preventing Cholestasis Using SMOFLipid®CompletedPhase 4Medical University of ViennaNCT01585935Written as INTRALIPID
- Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral NutritionCompletedPhase 3Thammasat UniversityNCT02663453Written as pure soybean oil lipid emulsion
- Evaluation of OMEGAVEN 10%® (n-3 EFA Lipid Emulsion) in Home Parenteral Nutrition-associated Liver DiseaseCompletedNot applicableAssistance Publique - Hôpitaux de ParisNCT01284049Written as Intralipid 20%®
- The Effect of Intravenous Lipids on Lung Function in Acute Respiratory Distress Syndrome (ARDS)TerminatedPhase 2Methodist Research Institute, IndianapolisNCT01096771Written as Intralipid 20%
- Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?Status unknownPhase 2The Hospital for Sick ChildrenNCT00793195Written as Intralipid 20%
- The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer PatientsCompletedPhase 3Sino-Swed Pharmaceutical CorporationNCT00292279Written as long-chain triglyceride
Codes
What other systems call soybean oil, phospholipid emulsion · ClinicalTrials.gg INT005543
- MeSH (NLM) C545823soybean oil, phospholipid emulsionOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C545823 | soybean oil, phospholipid emulsion | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.